Disclaimer

The alfapump® system is currently not approved in the United States or Canada. In the United States and Canada, the alfapump® system is currently under clinical investigation (POSEIDON Study) and is being studied in adult patients with refractory or recurrent ascites due to cirrhosis. DSR® therapy is still in development and it should be noted that any statements regarding safety and efficacy arise from ongoing pre-clinical and clinical investigations which have yet to be completed. There is no link between the DSR® therapy and ongoing investigations with the alfapump® system in Europe, the United States or Canada.

Contact us

BELGIUM

Headquarters

Sequana Medical NV
Kortrijksesteenweg 1112 box 102
9051 Sint-Denijs-Westrem

SWITZERLAND

Swiss Authorized Representative (CH-REP)

Sequana Medical NV
Technoparkstrasse 1
Building Darwin, 2nd floor
8005 Zurich

  • +41 44 403 55 00

GERMANY

Sequana Medical GmbH
Rundfunkplatz 2
80335 München

  • +49 89 38 03 84 05

US

Sequana Medical US Inc
265 Franklin Street , Suite 1702
Boston, MA 02110

Request information

For enquiries or to request information material, please use the contact form below.

    I agree to the Sequana Medical Privacy Policy

    Customer Service numbers

    Germany
    0800 72 44 872

    United Kingdom
    0800 069 84 89

    Switzerland
    +41 44403 55 29

    PRESS RELEASES

    SUBSCRIBE TO OUR PRESS RELEASES